Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1181 of 6351
-
Breathalyzer for lung cancer? new study tests AI-Powered nodule detection
Diagnosis Recruiting nowThe goal of this observational study is to develop an advanced expiratory algorithm model utilizing exhaled breath volatile organic compound (VOC) markers. This model aims to accurately differentiate benign from malignant nodules in individuals harboring pulmonary nodules. The pr…
Sponsor: ChromX Health • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
A card game could open the door to better End-of-Life conversations
Symptom relief CompletedThe goal of this clinical trial is to explore feasibility, acceptability, and effectiveness of end-of-life conversation game "Hello" as a tool to help individuals with various solid cancer types (including: breast, gastro-intestinal, lung, melanoma, head and neck, and/or genito-u…
Sponsor: Milton S. Hershey Medical Center • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Artificial cornea implant aims to restore sight in the blind
Disease control Stopped earlyA Single Arm, Pivotal, Open Label, Multicenter Clinical Investigation to Evaluate the Clinical Safety and Performance of the CorNeat Keratoprosthesis, for Treatment of Corneal Blindness
Sponsor: CorNeat Vision Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New inhaled drug shows promise for cystic fibrosis in early trial
Disease control CompletedThis study is the first to give ETD001 to people with CF. The study will be run in two parts. Part A will assess if ETD001 is safe to give to people with CF, and Part B will assess if ETD001 improves lung function. The study drug is taken twice a day, in Part A it is taken for 7 …
Phase 2 • Sponsor: Enterprise Therapeutics Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Strength training may boost heart transplant candidates' fitness and quality of life
Symptom relief Recruiting nowThe present longitudinal, randomized, and blinded clinical trial aims to: * Evaluate the effects of resistance training on the functional capacity, quality of life, and cardiac biomarkers of hospitalized patients with heart failure (HF) on the waiting list for heart transplantat…
Sponsor: University of Sao Paulo General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New shingles vaccine Z-1018 takes on shingrix in Head-to-Head trial
Vaccine OngoingThis is a randomized, active-controlled, observer-blinded, dose-escalation multi-center trial of 2 doses of an investigational HZ vaccine (Z-1018) in approximately 764 healthy adults.
Phase 1/2 • Sponsor: Dynavax Technologies Corporation • Aim: Vaccine
Last updated Jun 27, 2026 13:00 UTC
-
New drug SHR6508 aims to tame hormone imbalance in dialysis patients
Disease control CompletedThe study is being conducted to evaluate the efficacy and safety of SHR6508 among Chinese patients with secondary hyperparathyroidism of chronic kidney disease treated by maintenance hemodialysis.
Phase 3 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug hope for kids with rare Muscle-Weakening disease
Disease control OngoingThe purpose of the study is to assess the safety and tolerability of subcutaneous (sc) administration of rozanolixizumab in pediatric participants aged ≥2 to \<18 years with generalized Myasthenia Gravis (gMG).
Phase 2/3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New imaging agent could sharpen prostate cancer staging
Diagnosis Recruiting nowThis study assess the Diagnostic Performance of \[18F\]PSMA-1007 PET/CT Imaging in Patients with Newly-Diagnosed High-Risk or Very-High-Risk Prostate Cancer
Phase 3 • Sponsor: ABX advanced biochemical compounds GmbH • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
Robotic legs may retrain walking in Parkinson's — a trial puts the tech to the test
Symptom relief OngoingThe goal of this study is to see how well therapy with the Eksobionic Exoskeleton (Esko) works for people with Parkinson's disease (PWPD). Esko is a robotic device that provides high repetition and intensity training. The investigators will examine its impact on walking, balance,…
Sponsor: Albert Einstein Healthcare Network • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
New study tests if office-based methadone keeps more people in opioid addiction treatment than buprenorphine
Disease control Recruiting nowThe purpose of this clinical trial is to compare the effectiveness of office-based methadone with pharmacy administration and/or dispensing to office-based buprenorphine for the treatment of opioid use disorder. This study will also examine factors influencing the implementation …
Phase 4 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New pill shows promise for Long-Term smoking and vaping cessation
Disease control CompletedSafety assessment of long-term 3 mg cytisinicline three times daily (TID) exposure for 52 weeks is the main purpose of this study, conducted in the United States.
Phase 3 • Sponsor: Achieve Life Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
AI spots silent heart condition in seconds
Diagnosis CompletedThis is a single center, diagnostic clinical trial in which the investigators aim to prospectively validate a deep learning model that identifies patients with features suggestive of cardiac amyloidosis, including transthyretin cardiac amyloidosis (ATTR-CA). Cardiac Amyloidosis …
Sponsor: Pierre Elias • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
New drug aims to tackle sleepiness in rare genetic disorder
Symptom relief Recruiting nowThis is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, global clinical study to assess the efficacy and safety of pitolisant in patients living with Prader-Willi syndrome. The primary objective of this study is to evaluate the efficacy of pitolisant in tre…
Phase 3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
New ADHD pill for kids shows promise in Late-Stage trial
Disease control CompletedThis study is a Phase 3, multicenter, dose-optimized, double-blind, randomized, placebo-controlled study designed to evaluate the efficacy, safety, and tolerability of oral AK0901 capsules in children 6 to 12 years old with Attention Deficit Hyperactivity Disorder(ADHD).
Phase 3 • Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New pill aims to tame mania in bipolar disorder
Disease control CompletedThe purpose of this study is to determine whether BHV-7000 is a safe and effective acute treatment for manic episodes in bipolar disorder I.
Phase 2/3 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New stem cell combo aims to tame leukemia in older patients
Disease control Recruiting nowThis phase I trial tests the side effects and best dose of total marrow lymphoid irradiation along with chemotherapy, with fludarabine and melphalan, with or without thiotepa, in combination with Orca-T cells for patients with acute myeloid leukemia (AML), acute lymphoblastic leu…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Bee product may boost health in oral cancer survivors
Disease control CompletedThis study examined whether Taiwanese Green Propolis (TGP), a natural bee-derived supplement, can improve blood fat levels, reduce tiredness (fatigue), and improve quality of life in people who have completed treatment for oral cavity (mouth) cancer. People who had finished trea…
Sponsor: Taipei Medical University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for young kidney transplant patients: safer drug combo tested
Disease control Recruiting nowThis is a pediatric kidney transplant study comparing the safety and efficacy of an immunosuppressive regimen of belatacept and sirolimus to tacrolimus and Mycophenolate Mofetil (MMF). Two hundred participants will be randomized (1:1) to one of two groups within 24 hours followin…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Magnetic pulses may rewire brain connections in schizophrenia
Disease control Recruiting nowPatients with schizophrenia spectrum disorder (SSD) will be exposed to active repetitive transcranial magnetic stimulation (rTMS) from H coil for improving white matter integrity.
Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC